CN101696449A - 核酸芯片、其制备方法及用途 - Google Patents
核酸芯片、其制备方法及用途 Download PDFInfo
- Publication number
- CN101696449A CN101696449A CN200910210565A CN200910210565A CN101696449A CN 101696449 A CN101696449 A CN 101696449A CN 200910210565 A CN200910210565 A CN 200910210565A CN 200910210565 A CN200910210565 A CN 200910210565A CN 101696449 A CN101696449 A CN 101696449A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- cell
- chip
- substrate
- acid chip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 127
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 125
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 125
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 78
- 239000000758 substrate Substances 0.000 claims abstract description 39
- 108020004459 Small interfering RNA Proteins 0.000 claims abstract description 38
- 230000012292 cell migration Effects 0.000 claims abstract description 23
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 17
- 239000013612 plasmid Substances 0.000 claims abstract description 11
- 239000000560 biocompatible material Substances 0.000 claims abstract description 7
- 108091062183 EsiRNA Proteins 0.000 claims abstract description 6
- 108020004414 DNA Proteins 0.000 claims abstract description 5
- 230000006907 apoptotic process Effects 0.000 claims abstract description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229920001661 Chitosan Polymers 0.000 claims abstract description 4
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 4
- 239000004584 polyacrylic acid Substances 0.000 claims abstract description 4
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 4
- 239000000661 sodium alginate Substances 0.000 claims abstract description 4
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 46
- 238000001890 transfection Methods 0.000 claims description 35
- 239000002502 liposome Substances 0.000 claims description 27
- 239000012096 transfection reagent Substances 0.000 claims description 27
- 239000011159 matrix material Substances 0.000 claims description 19
- 230000012010 growth Effects 0.000 claims description 18
- 229920002120 photoresistant polymer Polymers 0.000 claims description 18
- 230000003915 cell function Effects 0.000 claims description 13
- 238000005530 etching Methods 0.000 claims description 13
- -1 polyethylene Polymers 0.000 claims description 13
- 108010010803 Gelatin Proteins 0.000 claims description 12
- 239000008273 gelatin Substances 0.000 claims description 12
- 229920000159 gelatin Polymers 0.000 claims description 12
- 235000019322 gelatine Nutrition 0.000 claims description 12
- 235000011852 gelatine desserts Nutrition 0.000 claims description 12
- 102000016359 Fibronectins Human genes 0.000 claims description 11
- 108010067306 Fibronectins Proteins 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 230000008859 change Effects 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 8
- 235000015097 nutrients Nutrition 0.000 claims description 8
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 claims description 8
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 6
- 229920001400 block copolymer Polymers 0.000 claims description 6
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 6
- 229920001451 polypropylene glycol Polymers 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 239000010703 silicon Substances 0.000 claims description 6
- 229910052710 silicon Inorganic materials 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- 238000001020 plasma etching Methods 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- BPMFZUMJYQTVII-UHFFFAOYSA-N guanidinoacetic acid Chemical compound NC(=N)NCC(O)=O BPMFZUMJYQTVII-UHFFFAOYSA-N 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims description 4
- 239000000017 hydrogel Substances 0.000 claims description 4
- 229920002492 poly(sulfone) Polymers 0.000 claims description 4
- 239000004417 polycarbonate Substances 0.000 claims description 4
- 229920000515 polycarbonate Polymers 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 4
- 229920000098 polyolefin Polymers 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 4
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 claims description 3
- MXRGSJAOLKBZLU-UHFFFAOYSA-N 3-ethenylazepan-2-one Chemical compound C=CC1CCCCNC1=O MXRGSJAOLKBZLU-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- 229920001519 homopolymer Polymers 0.000 claims description 3
- 229920002239 polyacrylonitrile Polymers 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 229920000954 Polyglycolide Polymers 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 230000004900 autophagic degradation Effects 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 229910001882 dioxygen Inorganic materials 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000036961 partial effect Effects 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 27
- 238000012216 screening Methods 0.000 abstract description 9
- 238000001514 detection method Methods 0.000 abstract description 4
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 abstract description 3
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 230000010261 cell growth Effects 0.000 abstract description 2
- 244000005700 microbiome Species 0.000 abstract description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 abstract 2
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 91
- 239000000243 solution Substances 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
- 238000011160 research Methods 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 11
- 108091027967 Small hairpin RNA Proteins 0.000 description 8
- 239000004055 small Interfering RNA Substances 0.000 description 8
- 238000004113 cell culture Methods 0.000 description 6
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 5
- 108091030071 RNAI Proteins 0.000 description 5
- 230000009368 gene silencing by RNA Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 239000012097 Lipofectamine 2000 Substances 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 238000003499 nucleic acid array Methods 0.000 description 2
- 238000000206 photolithography Methods 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012124 Opti-MEM Substances 0.000 description 1
- 102000014160 PTEN Phosphohydrolase Human genes 0.000 description 1
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 229920001486 SU-8 photoresist Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 101150103518 bar gene Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000024835 cytogamy Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 230000008442 fetal wound healing Effects 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 210000004332 phalangeal cell Anatomy 0.000 description 1
- 238000000016 photochemical curing Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000003584 silencer Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000002520 smart material Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00608—DNA chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00635—Introduction of reactive groups to the surface by reactive plasma treatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/0074—Biological products
- B01J2219/00743—Cells
Abstract
Description
Claims (28)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910210565.1A CN101696449B (zh) | 2009-11-10 | 2009-11-10 | 核酸芯片、其制备方法及用途 |
PCT/CN2010/001583 WO2011057467A1 (zh) | 2009-11-10 | 2010-10-09 | 核酸芯片、其制备方法及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910210565.1A CN101696449B (zh) | 2009-11-10 | 2009-11-10 | 核酸芯片、其制备方法及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101696449A true CN101696449A (zh) | 2010-04-21 |
CN101696449B CN101696449B (zh) | 2017-05-17 |
Family
ID=42141575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910210565.1A Active CN101696449B (zh) | 2009-11-10 | 2009-11-10 | 核酸芯片、其制备方法及用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101696449B (zh) |
WO (1) | WO2011057467A1 (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011057467A1 (zh) * | 2009-11-10 | 2011-05-19 | Xi Jianzhong | 核酸芯片、其制备方法及用途 |
CN102586224A (zh) * | 2011-01-14 | 2012-07-18 | 北京大学 | 一种简单、快速制备即用esiRNA的方法 |
CN103197066A (zh) * | 2013-03-07 | 2013-07-10 | 美国纳米材料创新有限公司 | 一种免疫脂质体生物芯片、其制备方法及其在生物检测中的应用 |
CN103966155A (zh) * | 2013-04-25 | 2014-08-06 | 苏州吉诺瑞生物科技有限公司 | 一种利用自组装细胞芯片转染蛋白质或化合物的方法 |
CN105149023A (zh) * | 2010-06-30 | 2015-12-16 | 安派科生物医学科技有限公司 | 疾病检测仪 |
CN105463119A (zh) * | 2016-01-18 | 2016-04-06 | 苏州吉诺瑞生物科技有限公司 | 利用SAMcell芯片检测物质对细胞增殖影响的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1379810A (zh) * | 1999-07-07 | 2002-11-13 | 麦鲁斯公司 | 用于将核酸固定在固体支持物上的底物 |
CN101117423A (zh) * | 2006-06-12 | 2008-02-06 | 康宁股份有限公司 | 热敏性共混物及其应用 |
CN101200719A (zh) * | 2006-12-11 | 2008-06-18 | 上海人类基因组研究中心 | 肝癌相关基因dlk1及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101696449B (zh) * | 2009-11-10 | 2017-05-17 | 苏州吉玛基因股份有限公司 | 核酸芯片、其制备方法及用途 |
-
2009
- 2009-11-10 CN CN200910210565.1A patent/CN101696449B/zh active Active
-
2010
- 2010-10-09 WO PCT/CN2010/001583 patent/WO2011057467A1/zh active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1379810A (zh) * | 1999-07-07 | 2002-11-13 | 麦鲁斯公司 | 用于将核酸固定在固体支持物上的底物 |
CN101117423A (zh) * | 2006-06-12 | 2008-02-06 | 康宁股份有限公司 | 热敏性共混物及其应用 |
CN101200719A (zh) * | 2006-12-11 | 2008-06-18 | 上海人类基因组研究中心 | 肝癌相关基因dlk1及其应用 |
Non-Patent Citations (2)
Title |
---|
REIKO ONUKI-NAGASAKI等: "On-chip screening method for cell migration genes based on a transfection microarray", 《LAB CHIP》 * |
蒋稼欢: "《生物医学微系统技术及应用》", 31 March 2006 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011057467A1 (zh) * | 2009-11-10 | 2011-05-19 | Xi Jianzhong | 核酸芯片、其制备方法及用途 |
CN105149023A (zh) * | 2010-06-30 | 2015-12-16 | 安派科生物医学科技有限公司 | 疾病检测仪 |
CN105149023B (zh) * | 2010-06-30 | 2018-06-12 | 安派科生物医学科技有限公司 | 疾病检测仪 |
CN102586224A (zh) * | 2011-01-14 | 2012-07-18 | 北京大学 | 一种简单、快速制备即用esiRNA的方法 |
CN102586224B (zh) * | 2011-01-14 | 2014-05-28 | 北京大学 | 一种简单、快速制备即用esiRNA的方法 |
CN103197066A (zh) * | 2013-03-07 | 2013-07-10 | 美国纳米材料创新有限公司 | 一种免疫脂质体生物芯片、其制备方法及其在生物检测中的应用 |
CN103966155A (zh) * | 2013-04-25 | 2014-08-06 | 苏州吉诺瑞生物科技有限公司 | 一种利用自组装细胞芯片转染蛋白质或化合物的方法 |
WO2014173177A1 (zh) * | 2013-04-25 | 2014-10-30 | 苏州吉诺瑞生物科技有限公司 | 一种利用自组装细胞芯片转染蛋白质或化合物的方法 |
CN103966155B (zh) * | 2013-04-25 | 2016-03-02 | 苏州吉诺瑞生物科技有限公司 | 一种利用自组装细胞芯片转染蛋白质或化合物的方法 |
CN105463119A (zh) * | 2016-01-18 | 2016-04-06 | 苏州吉诺瑞生物科技有限公司 | 利用SAMcell芯片检测物质对细胞增殖影响的方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2011057467A1 (zh) | 2011-05-19 |
CN101696449B (zh) | 2017-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101696449A (zh) | 核酸芯片、其制备方法及用途 | |
Chen et al. | Functional polymer surfaces for controlling cell behaviors | |
CN105861309B (zh) | 一种超疏水微坑阵列芯片及其制备方法与应用 | |
CN102056983B (zh) | 有机无机复合物分散液及使用该分散液制造的细胞培养基材以及它们的制造方法 | |
CN103421691B (zh) | 一种基于微流体构图技术的单细胞阵列培养玻璃芯片及其制备方法 | |
WO2006114097A2 (en) | Biosurface structure array | |
JP2006513703A5 (zh) | ||
CN102719352B (zh) | 一种用于制备微阵列细胞芯片的细胞芯片片基及制备方法 | |
CN102046773A (zh) | 具有不同微孔外形的细胞培养装置 | |
CN103710263B (zh) | 细胞培养装置 | |
Cheptsov et al. | New microorganism isolation techniques with emphasis on laser printing | |
EP2045598A2 (en) | Cellular microarray and its microfabrication method | |
CN106479893B (zh) | 一种多种细胞图案化共培养的装置及方法 | |
CN105504327A (zh) | 一种具有3d微图案的生物材料及其制备方法 | |
WO2013015939A1 (en) | Composite substrate for 3d cell culture | |
EP2470640B1 (en) | Microfluidic system and method for producing same | |
Zhang et al. | Agarose-based microwell array chip for high-throughput screening of functional microorganisms | |
Tavana et al. | Aqueous biphasic microprinting approach to tissue engineering | |
JP2008173018A (ja) | 細胞培養方法及び細胞培養用基板 | |
Hsieh et al. | Patterned PDMS based cell array system: a novel method for fast cell array fabrication | |
JP5164156B2 (ja) | インクジェット印刷技術を用いた基板上への細胞のパターンニング | |
CN203065491U (zh) | 细胞培养装置 | |
Liu et al. | Development of a single-cell array for large-scale DNA fluorescence in situ hybridization | |
CN101748060B (zh) | 将多种细胞排列于同一平面并对其进行操控的装置及方法 | |
KR101218982B1 (ko) | 세포 칩, 이의 제조방법 및 세포 칩 제조장치 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: SUZHOU GENEPHARMA CO., LTD. Free format text: FORMER OWNER: PEKING UNIVERSITY Effective date: 20120803 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100871 HAIDIAN, BEIJING TO: 215123 SUZHOU, JIANGSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120803 Address after: 215123 No. 199, Dongping street, Suzhou Industrial Park, Jiangsu Province Applicant after: Suzhou GenePharma Co. Ltd. Address before: 100871 Beijing the Summer Palace Road, Haidian District, No. 5 Applicant before: Peking University |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181128 Address after: 100193 room 4, 4 building, 3 building, 29 Northeast Road, Haidian District, Beijing. Patentee after: Beijing Gishanley de biological science and Technology Co Ltd Address before: 215123 No. 199 Dongping Street, Suzhou Industrial Park, Jiangsu Province Patentee before: Suzhou GenePharma Co. Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210721 Address after: 100195 Beijing Haidian Xingshikou Road Yiyuan Cultural and Creative Industry Base Area C West Section of Building 11 201 Patentee after: BEIJING GENEX HEALTH TECHNOLOGY Co.,Ltd. Address before: 100193 room 4, 4 building, 3 building, 29 Northeast Road, Haidian District, Beijing. Patentee before: BEIJING JISHANG LIDE BIOLOGY TECHNOLOGY Co.,Ltd. |